P.2.a.028 The effect of the number of depressive episodes on fatigue in female patients with major depression von Ferentinos, P, Kontaxakis, V.P, Havaki-Kontaxaki, B.J, Dikeos, D, Papadimitriou, G.N, Lykouras, L

Volltext

P.1.a.010 The contribution of genetic vulnerability to the multiformity of isotretinoin-induced psychiatric adverse events von Kontaxakis, V.P, Ferentinos, P, Havald-Kontaxató, B, Papadimitriou, G.N

Volltext

P.2.a.017 Fatigue questionnaire: sensitivity to changes in depression severity in depressed patients von Ferentinos, P, Kontaxakis, V.P, Havaki-Kontaxaki, B, Dikeos, D, Papadimitriou, G.N

Volltext

P.2.a.030 Fatigue correlates in major depression: preliminary findings von Ferentinos, P.P., Kontaxakis, V.P., Havaki-Kontaxaki, B.J., Dikeos, D.G., Soldatos, C.R.

Volltext

P.2.160 Combination treatment with risperidone and diazepam in drug-naive schizophrenic patients von Kontaxakis, V.P., Havaki-Kontaxaki, B.J., Stamouli, S.S., Christodoulou, G.N.

Volltext

P.1.113 Serum total cholesterol and triglycerides in suicide attempters: Comparison with schizophrenic patients and healthy subjects von Kontaxakis, V.P., Paplos, K.G., Havaki-Kontaxaki, B.J., Christodoulou, G.N.

Volltext

P.2.088 Concurrent use of clozapine and ECT as anaugmentation strategy in clozapine-resistant schizophrenic patients von Havaki-Kontaxaki, B.J., Ferentinos, P.P., Kontaxakis, V.P., Peplos, K.G., Christodoulou, G.N.

Volltext

P.2.086 Amisulpride in clozapine-resistant schizophrenia von Kontaxakis, V.P., Havaki-Kontaxaki, B.J., Paplos, K.G., Ferentinos, P.P., Christodoulou, G.N.

Volltext

P.1.112 Serum lipids, depression and anhedonia in suicide attempters von Paplos, K.G., Kontaxakis, V.P., Havaki-Kontaxaki, B.J., Alaveras, A.G., Issidorides, M.R., Christodoulou, G.N.

Volltext

Coexistence of neuroleptic-induced movement side-effects: A comparative study von Havaki-Kontaxaki, B.J., Kontaxakis, V.P., Christodoulou, G.N.

Volltext

Neuroleptic malignant syndrome induced by risperidone and clozapine combination von Kontaxakis, V.P., Havaki-Kontaxaki, B.J., Stamouli, S.S., Christodoulou, G.N.

Volltext

Optimal risperidone dosage in drug-naïve first-episode schizophrenic patients von Kontaxakis, V.P., Havaki-Kontaxaki, B.J., Stamouli, S.S., Christodoulou, G.N.

Volltext

Prevalence and characteristics of patients with pseudoakathisia von Havaki-Kontaxaki, B.J., Kontaxakis, V.P., Christodoulou, G.N.

Volltext

P.2.036 Neuroleptic malignant syndrome symptomatology in psychiatric inpatients von Havaki-Kontaxaki, B.J., Kontaxakis, V.P., Christodoulou, G.N.

Volltext

Atypical antipsychotics' use among acute schizophrenic inpatients von Kontaxakis, V.P., Havaki-Kontaxaki, B.J., Kollias, C.T., Margariti, M.M., Stamouli, S.S., Christodoulou, G.N.

Volltext

Olanzapine-associated neuroleptic malignant syndrome: Is there any overlap with the serotonin syndrome? von Kontaxakis, V.P., Havaki-Kontaxaki, B.J., Christodoulou, N.G., Paplos, K.G., Christodoulou, G.N.

Volltext

The use of atypical antipsychotics in the university psychiatric hospital in Athens von Kontaxakis, V.P., Havaki-Kontaxaki, B.J., Kollias, C., Stamouli, S., Margariti, M., Christodoulou, G.N.

Volltext

Olanzapine-induced neuroleptic malignant syndrome von Kontaxakis, V.P., Havaki-Kontaxaki, B.J., Christodoulou, N.G., Paplos, K.G., Christodoulou, G.N.

Volltext

Anhedonia and negative symptomatology in acute schizophrenic inpatients von Kollias, C.T., Kontaxakis, V.P., Havaki-Kontaxaki, B.J., Margariti, M., Stamouli, S., Trikkas, G., Christodoulou, G.N.

Volltext

Depression measures and motor side-effects among schizophrenic inpatients von Kontaxakis, V.P., Havaki-Kontaxaki, B.J., Stamouli, S., Margariti, M., Kollias, C., Christodoulou, G.N.

Volltext